1. Home
  2. GSAT vs PODD Comparison

GSAT vs PODD Comparison

Compare GSAT & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$82.36

Market Cap

10.7B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$148.16

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSAT
PODD
Founded
2003
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
10.3B
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
GSAT
PODD
Price
$82.36
$148.16
Analyst Decision
Strong Buy
Buy
Analyst Count
2
21
Target Price
$70.50
$341.48
AVG Volume (30 Days)
988.2K
1.7M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
74.58
N/A
EPS
N/A
2.67
Revenue
$112,660,000.00
$2,708,100,000.00
Revenue This Year
$10.31
$24.55
Revenue Next Year
$15.93
$19.18
P/E Ratio
N/A
$55.01
Revenue Growth
N/A
30.73
52 Week Low
$26.45
$126.40
52 Week High
$84.85
$354.88

Technical Indicators

Market Signals
Indicator
GSAT
PODD
Relative Strength Index (RSI) 52.33 46.91
Support Level $81.84 $141.67
Resistance Level $82.51 $167.98
Average True Range (ATR) 0.77 6.32
MACD -0.14 0.08
Stochastic Oscillator 19.82 49.41

Price Performance

Historical Comparison
GSAT
PODD

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: